• Mashup Score: 55
    Tuberculosis (TB) - 1 year(s) ago

    Tuberculosis is caused by bacteria that most often affect the lungs. TB is curable and preventable and is spread from person to person through the air.

    Source: www.who.int
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of WHO
      WHO

      It's World Tuberculosis Day. Tuberculosis - or TB - is caused by bacteria Mycobacterium tuberculosis that most often affect the lungs. #Tuberculosis is curable and preventable https://t.co/NQ5A5GuMrA #EndTB #WorldTBDay https://t.co/LPga9ABYuN

  • Mashup Score: 42
    WHO announces plans to establish a TB Vaccine Accelerator council - 1 year(s) ago

    The adverse impact of the COVID-19 pandemic on tuberculosis (TB) services has brought the urgency of vaccine development efforts into sharp focus. Speaking earlier today at a high-level panel on TB at the World Economic Forum, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, announced plans to establish a new TB Vaccine Accelerator Council. The Council will…

    Source: www.who.int
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DrTedros
      DrTedros

      One key lesson from #COVID19 is that innovative health interventions can be delivered rapidly, if they are prioritized politically and financed adequately. We believe the #tuberculosis field will benefit from similar high-level coordination. https://t.co/3NdhSMlzd7 #wef23 #EndTB

  • Mashup Score: 3
    UNITE4TB Newsletter: December 2022 - 1 year(s) ago

    Welcome to the latest edition of the UNITE4TB Newsletter, in which we share a round-up of recent project news and activities. Please don’t hesitate to reach out if you would like to find out more about our mission to accelerate the development of new treatment regimens for tuberculosis (TB). If you haven’t already done so, make sure to follow us on LinkedIn, Twitter, and YouTube. Thank you for…

    Source: mailchi.mp
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of EuroRespSoc
      EuroRespSoc

      RT @UNITE4TB: Catch up on the latest news from UNITE4TB in our #newsletter, just out 👉 https://t.co/3J29NaFncK #tuberculosis #EndTB #SaveL…

  • Mashup Score: 0
    Tuberculosis control: getting back on track in the era of COVID-19 - 2 year(s) ago

    A new report by WHO has laid bare the worrying extent to which the COVID-19 pandemic has disrupted efforts to combat tuberculosis. At the centre of the 2022 Global Tuberculosis Report are the statistics on case notifications. In 2019, the year before the COVID-19 pandemic was declared, 7·1 million new cases of tuberculosis were reported worldwide. In 2020, this number dropped to 5·8 million,…

    Source: The Lancet Respiratory Medicine
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of LancetRespirMed
      LancetRespirMed

      NEWS—#TB control: getting back on track in the era of #COVID19 https://t.co/MMzRwNBqlF Published as experts and advocates meet at #UnionConf @UnionConference @WHO @StopTB @TerezaKasaeva @SahuSuvanand #LungHealth #EndTB https://t.co/l5YNTJbL6g

  • Mashup Score: 1
    Long-acting implant-forming formulation of anti-tuberculosis drug rifabutin - 2 year(s) ago

    Tuberculosis (TB) is a bacterial disease caused by Mycobacterium tuberculosis (Mtb) that usually affects the lung, but it can also affect other parts of the body. It is often thought to be a disease from the past. However, it remains one of the main killer infectious diseases, particularly in developing countries. Moreover, approximately one-fourth of the world’s population has a latent TB…

    Source: Nature Portfolio Bioengineering Community
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NatureComms
      NatureComms

      Long-acting implant-forming formulation of anti-tuberculosis drug rifabutin @UNC @UNC_ID @uncglobalhealth @UNC_Micro_Imm #EndTB #DrugDevelopment #Tuberculosis #LongActingTreatment https://t.co/kw4QZXtVp0

Load More